Search

everythinglearnresearchcommunity

for

Search:↓

Some alopecia treatments might help treat COVID-19, but more research is needed.

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Insulin resistance is strongly linked to higher androgen levels in women with PCOS.

Ancient hair can preserve hormones, revealing health and fertility insights.

High TNF-α levels may increase hair loss risk after PRP therapy.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

PCOS has many symptoms, with high androgen levels being the most common.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Fat cells are important for tissue repair and stem cell support in various body parts.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Future acne treatments should aggressively target inflammation to prevent scarring.

Small molecule drugs show promise for advancing regenerative medicine but still face development challenges.

Using neurohormones to control keratin can lead to new skin disease treatments.